vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and LiveRamp Holdings, Inc. (RAMP). Click either name above to swap in a different company.
LiveRamp Holdings, Inc. is the larger business by last-quarter revenue ($212.2M vs $164.7M, roughly 1.3× PTC THERAPEUTICS, INC.). LiveRamp Holdings, Inc. runs the higher net margin — 18.8% vs -82.0%, a 100.7% gap on every dollar of revenue. On growth, LiveRamp Holdings, Inc. posted the faster year-over-year revenue change (8.6% vs -22.7%). Over the past eight quarters, LiveRamp Holdings, Inc.'s revenue compounded faster (11.1% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
LiveRamp Holdings, Inc., is an American SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
PTCT vs RAMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $212.2M |
| Net Profit | $-135.0M | $39.9M |
| Gross Margin | — | 71.9% |
| Operating Margin | -43.3% | 18.6% |
| Net Margin | -82.0% | 18.8% |
| Revenue YoY | -22.7% | 8.6% |
| Net Profit YoY | -104.8% | 255.7% |
| EPS (diluted) | $-1.63 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $212.2M | ||
| Q3 25 | $211.0M | $199.8M | ||
| Q2 25 | $178.9M | $194.8M | ||
| Q1 25 | $1.2B | $188.7M | ||
| Q4 24 | $213.2M | $195.4M | ||
| Q3 24 | $196.8M | $185.5M | ||
| Q2 24 | $186.7M | $176.0M | ||
| Q1 24 | $210.1M | $171.9M |
| Q4 25 | $-135.0M | $39.9M | ||
| Q3 25 | $15.9M | $27.4M | ||
| Q2 25 | $-64.8M | $7.7M | ||
| Q1 25 | $866.6M | $-6.3M | ||
| Q4 24 | $-65.9M | $11.2M | ||
| Q3 24 | $-106.7M | $1.7M | ||
| Q2 24 | $-99.2M | $-7.5M | ||
| Q1 24 | $-91.6M | $-5.4M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.1% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
| Q4 25 | -43.3% | 18.6% | ||
| Q3 25 | 1.4% | 10.7% | ||
| Q2 25 | -19.5% | 3.7% | ||
| Q1 25 | 82.5% | -6.1% | ||
| Q4 24 | -76.2% | 7.5% | ||
| Q3 24 | -27.7% | 4.0% | ||
| Q2 24 | -21.5% | -3.0% | ||
| Q1 24 | -21.6% | -8.3% |
| Q4 25 | -82.0% | 18.8% | ||
| Q3 25 | 7.5% | 13.7% | ||
| Q2 25 | -36.3% | 4.0% | ||
| Q1 25 | 73.7% | -3.3% | ||
| Q4 24 | -30.9% | 5.7% | ||
| Q3 24 | -54.2% | 0.9% | ||
| Q2 24 | -53.1% | -4.3% | ||
| Q1 24 | -43.6% | -3.1% |
| Q4 25 | $-1.63 | $0.62 | ||
| Q3 25 | $0.20 | $0.42 | ||
| Q2 25 | $-0.83 | $0.12 | ||
| Q1 25 | $10.04 | $-0.10 | ||
| Q4 24 | $-0.85 | $0.17 | ||
| Q3 24 | $-1.39 | $0.03 | ||
| Q2 24 | $-1.29 | $-0.11 | ||
| Q1 24 | $-1.20 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $403.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $962.3M |
| Total Assets | $2.9B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $403.4M | ||
| Q3 25 | $1.7B | $376.9M | ||
| Q2 25 | $2.0B | $371.1M | ||
| Q1 25 | $2.0B | $420.8M | ||
| Q4 24 | $1.1B | $384.3M | ||
| Q3 24 | $1.0B | $348.4M | ||
| Q2 24 | $1.1B | $342.7M | ||
| Q1 24 | $884.8M | $368.9M |
| Q4 25 | $-205.3M | $962.3M | ||
| Q3 25 | $-155.8M | $943.8M | ||
| Q2 25 | $-206.5M | $947.8M | ||
| Q1 25 | $-185.8M | $948.9M | ||
| Q4 24 | $-1.1B | $957.7M | ||
| Q3 24 | $-1.1B | $932.1M | ||
| Q2 24 | $-980.2M | $951.9M | ||
| Q1 24 | $-893.9M | $949.1M |
| Q4 25 | $2.9B | $1.3B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.8B | $1.2B | ||
| Q2 24 | $1.9B | $1.2B | ||
| Q1 24 | $1.8B | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | — |
| Free Cash FlowOCF − Capex | $-36.6M | — |
| FCF MarginFCF / Revenue | -22.3% | — |
| Capex IntensityCapex / Revenue | 1.4% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | — | ||
| Q3 25 | $-66.3M | $57.4M | ||
| Q2 25 | $-58.3M | $-15.8M | ||
| Q1 25 | $870.1M | — | ||
| Q4 24 | $-30.0M | $45.1M | ||
| Q3 24 | $-77.0M | $55.6M | ||
| Q2 24 | $-71.5M | $-9.3M | ||
| Q1 24 | $70.8M | — |
| Q4 25 | $-36.6M | — | ||
| Q3 25 | $-69.7M | $56.8M | ||
| Q2 25 | $-59.6M | $-16.2M | ||
| Q1 25 | $868.4M | — | ||
| Q4 24 | $-33.8M | $44.8M | ||
| Q3 24 | $-77.5M | $55.4M | ||
| Q2 24 | $-78.8M | $-9.6M | ||
| Q1 24 | $61.2M | — |
| Q4 25 | -22.3% | — | ||
| Q3 25 | -33.1% | 28.4% | ||
| Q2 25 | -33.3% | -8.3% | ||
| Q1 25 | 73.8% | — | ||
| Q4 24 | -15.8% | 22.9% | ||
| Q3 24 | -39.4% | 29.8% | ||
| Q2 24 | -42.2% | -5.4% | ||
| Q1 24 | 29.1% | — |
| Q4 25 | 1.4% | 0.1% | ||
| Q3 25 | 1.6% | 0.3% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 1.8% | 0.1% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 4.0% | 0.1% | ||
| Q1 24 | 4.6% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | -4.17× | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
